Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
Authors:
- Pietro LeccesePLPietro Leccese
- Salvatore D'AngeloSDSalvatore D'Angelo
- Padula AngelaPAPadula Angela
- Gabriella ConiglioGCGabriella Coniglio
- Ignazio OlivieriIOIgnazio Olivieri